228 related articles for article (PubMed ID: 24780744)
1. In vivo anticancer synergy mechanism of doxorubicin and verapamil combination treatment is impaired in BALB/c mice with metastatic breast cancer.
McCarthy M; Auda G; Agrawal S; Taylor A; Backstrom Z; Mondal D; Moroz K; Dash S
Exp Mol Pathol; 2014 Aug; 97(1):6-15. PubMed ID: 24780744
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model.
Bao L; Haque A; Jackson K; Hazari S; Moroz K; Jetly R; Dash S
Am J Pathol; 2011 Feb; 178(2):838-52. PubMed ID: 21281816
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral expression of mature human neutrophil peptide-1 potentiates the therapeutic effect of doxorubicin in a mouse 4T1 breast cancer model.
Li D; Qin Q; Wang XY; Shi HS; Luo M; Guo FC; Wang W; Wang YS
Oncol Rep; 2014 Mar; 31(3):1287-95. PubMed ID: 24378474
[TBL] [Abstract][Full Text] [Related]
4. Adriamycin in combination with dexamethasone and octreotide lacks activity on the treatment of a 4T1 metastatic breast cancer model.
Dalezis P; Trafalis DT; Geromichalos GD; Pissimissis N; Panagiotopoulou D; Galaktidou G; Papageorgiou E; Papageorgiou A; Lymperi M; Koutsilieris M
Anticancer Drugs; 2017 Jun; 28(5):489-502. PubMed ID: 28272098
[TBL] [Abstract][Full Text] [Related]
5. Delineating the anti-metastatic potential of pentoxifylline in combination with liposomal doxorubicin against breast cancer cells.
Goel PN; Gude RP
Biomed Pharmacother; 2014 Mar; 68(2):191-200. PubMed ID: 24373697
[TBL] [Abstract][Full Text] [Related]
6. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM
Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
[TBL] [Abstract][Full Text] [Related]
7. Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres.
Liu Z; Ballinger JR; Rauth AM; Bendayan R; Wu XY
J Pharm Pharmacol; 2003 Aug; 55(8):1063-73. PubMed ID: 12956895
[TBL] [Abstract][Full Text] [Related]
8. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.
Singh RP; Mallikarjuna GU; Sharma G; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
Clin Cancer Res; 2004 Dec; 10(24):8641-7. PubMed ID: 15623648
[TBL] [Abstract][Full Text] [Related]
9. Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma.
Zhang SH; Zhang H; He HW; Li L; Li XQ; Zhang YP; Shao RG
Cancer Chemother Pharmacol; 2013 Oct; 72(4):777-88. PubMed ID: 23975242
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer model.
de Souza CM; Araújo e Silva AC; de Jesus Ferraciolli C; Moreira GV; Campos LC; dos Reis DC; Lopes MT; Ferreira MA; Andrade SP; Cassali GD
Biomed Pharmacother; 2014 Feb; 68(1):51-7. PubMed ID: 24054045
[TBL] [Abstract][Full Text] [Related]
11. Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of mice.
Frings PW; Van Elssen CH; Wieten L; Matos C; Hupperets PS; Schouten HC; Bos GM; van Gelder M
Breast Cancer Res Treat; 2011 Dec; 130(3):773-81. PubMed ID: 21274621
[TBL] [Abstract][Full Text] [Related]
12. Effects of Dex-Verapamil on Doxorubicin cytotoxicity in P388 murine leukemia cells.
Noviello E; Allievi E; Russo P; Parodi S
Anticancer Drug Des; 1997 Jun; 12(4):261-76. PubMed ID: 9199659
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.
Liu CM; Lee WC; Yu CY; Lan KL; Chang CH; Ting G; Lee TW
Oncol Rep; 2012 Mar; 27(3):678-84. PubMed ID: 22109644
[TBL] [Abstract][Full Text] [Related]
14. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
[TBL] [Abstract][Full Text] [Related]
15. Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells.
Mantena SK; Baliga MS; Katiyar SK
Carcinogenesis; 2006 Aug; 27(8):1682-91. PubMed ID: 16597645
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice.
Kim EJ; Hong JE; Eom SJ; Lee JY; Park JH
Breast Cancer Res Treat; 2011 Nov; 130(1):61-71. PubMed ID: 21170677
[TBL] [Abstract][Full Text] [Related]
17. Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice.
Du G; Lin H; Yang Y; Zhang S; Wu X; Wang M; Ji L; Lu L; Yu L; Han G
Int Immunopharmacol; 2010 Jul; 10(7):819-26. PubMed ID: 20447470
[TBL] [Abstract][Full Text] [Related]
18. [Triptolide inhibits cell proliferation by downregulating phosphorylation of estrogen reporters in 4T1 tumor-bearing mice].
Pan GF; Gao JL; Zhang Q; Lv GY; Chen SH
Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(23):4129-33. PubMed ID: 24791503
[TBL] [Abstract][Full Text] [Related]
19. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
20. Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo.
Hossain MA; Kim DH; Jang JY; Kang YJ; Yoon JH; Moon JO; Chung HY; Kim GY; Choi YH; Copple BL; Kim ND
Int J Oncol; 2012 May; 40(5):1636-42. PubMed ID: 22322725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]